Setauket, NY, United States of America

Timothy Zamb


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 1999-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Timothy Zamb

Introduction

Timothy Zamb, an accomplished inventor based in Setauket, NY, has made significant contributions to the field of veterinary medicine through his innovative approaches to vaccines. With a total of two patents to his name, Zamb's work is centered around enhancing the health and well-being of cattle, specifically in combating bovine herpesvirus infections.

Latest Patents

Zamb's latest patents include groundbreaking advancements related to recombinant bovine herpesvirus type 1 (BHV-1) vaccines. These vaccines comprise compositions that utilize a pharmaceutically acceptable vehicle alongside a mutant strain of BHV-1. The innovative aspect of Zamb's work lies in the deletion or mutation of specific genes within the virus to create a more effective immunological response. One patent addresses vaccines having either a non-essential gene deleted or an essential gene mutated, along with methods for treating and preventing BHV-1 infections and other pathogens affecting cattle.

Additionally, Zamb has developed unique adjuvant formulations that enhance immunogenic activity. These formulations include quaternary ammonium salts combined with various oil components, which can significantly improve the immune response when used in conjunction with known immunological substances. His work not only targets viral infections but also includes a broader spectrum of bacterial pathogens in cattle.

Career Highlights

Timothy Zamb has forged a notable career within the University of Saskatchewan, where he continues to innovate in the field of veterinary vaccines. His research has been crucial in developing effective treatments and preventative measures against serious diseases that threaten livestock health.

Collaborations

Throughout his career, Zamb has collaborated with other esteemed professionals in the field, including Sylvia van Littel-van den Hurk and Mark J Redmond. These collaborations enhance his research capabilities and contribute to the ongoing development of effective veterinary medicines.

Conclusion

In conclusion, Timothy Zamb exemplifies the spirit of innovation in veterinary medicine with his contributions to BHV-1 vaccine development. His research not only supports the health of cattle but also addresses broader challenges in livestock disease management. With his expertise and collaborative efforts, Zamb is poised to continue making impactful advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…